medigraphic.com

2011, Number 4

<< Back Next >>

Rev Hematol Mex 2011; 12 (4)

Fusarium solani systemic sepsis in patients with acute leukemias. Report of two cases

Hernández-Cruz C, Núñez-Quintana A, Rodríguez-Fraga Y, Carnot-Uria J, Muñío-Perurena J, Pérez-Román G, Chávez-Medina R, Moya-Pérez I, Llanes-Rodríguez N, Hart-Casares M

Language: Spanish
References: 34
Page: 287-292
PDF size: 98.20 Kb.


ABSTRACT

The fungal infections in the immunocompromised population is a medical problem which has been raising during recent decades. The emergence of less common, but medically important fungi has increased, such as Fusarium sp. The first two cases in Cuba of disseminated infection are reported, both in patients with acute leukemias. The first one was a patient with a new onset acute lymphoblastic leukemia (ALL), and the other one was a case of monocytic (M5) acute myeloblastic leukemia, in his second complete remission, who underwent a bone marrow transplantation. Both cases developed the infection during the severe neutropenic period, starting with cellulitis on feet, and after that suffered necrotic lesions on skin and subcutaneous nodules. The ALL case was managed with conventional Amphotericin B formulation, liposomal Amphotericin B and Fluconazole that were administered in a sequential schedule; by that time the neutrophil count improved and the patient achieved his cure. The second case had a fatal outcome ten days after transplantation due to respiratory failure and in severe neutropenia. A brief review of the literature for Fusarium sp infection was carried out. The clinical features, the difficulties in the treatment and the poor prognosis of the patients in the setting of severe and prolonged neutropenia were confirmed.


REFERENCES

  1. Vusirikala M. Supportive Care in hematologic malignancies. In: Greer JP, Foerster J, Rodgers GM, Paraskevas F, et al. Wintrobe’s Clinical Hematology.12th ed. Philadelphia: Lippincott Williams & Wilkins, 2009;1759.

  2. Gea-Banacloche JC, Palmore T, Walsh TJ, Holland SM, Segal BH. Infections in the cancer patient. In: DeVita, Vincent T, Lawrence, Theodore S, et al. Principles and practice of Oncology. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2008;2006.

  3. Walsh TJ, Groll A, Hiemenz J, et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004;10 Suppl 1:48.

  4. Martino P, Gastaldi R, Raccah R, et al. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect 1994;28 Suppl 1:7-15.

  5. Halpern M, Balbi E, Carius L, et al. Cellulitis and nodular skin lesions due to Fusarium spp in liver transplant: case report. Transplant Proc 2010;42(2):599-600.

  6. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 1997;90(3):999-1008.

  7. I Venditti M, Micozzi A, Gentile G, et al. Invasive Fusarium solani infections in patients with acute leukemia. Rev Infect Dis 1988;10(3):653-660.

  8. Riehm H, Gadner H, Henze G, et al. Results and significance of six randomized trials in four consecutive ALL-BFM studies. Haematol Blood Transfus 1990;33:439-450.

  9. Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007;20(4):695-704.

  10. Guarro J, Nucci M, Akiti T, et al. Mixed infection caused by two species of Fusarium in a human immunodeficiency viruspositive patient. J Clin Microbiol 2000;38(9):3460-3462.

  11. Lionakis MS, Kontoyiannis DP. Fusarium infections in critically ill patients. Semin Respir Crit Care Med 2004;25(2):159-169.

  12. Cho CT, Vats TS, Lowman JT, et al. Fusarium solani infection during treatment for acute leukemia. J Pediatr 1973;83:1028.

  13. Campo M, Lewis RE, Kontoyiannis DP. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. J Infect 2010;60(5):331-337.

  14. Krcmery V, Jesenska Z, Spanik S, et al. Fungaemia due to Fusarium spp in cancer patients. J Hosp Infect 1997;36:223-228.

  15. Marr KA, Carter RA, Crippa F, et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002;34(7):909-917.

  16. Sampathkumar P, Paya CV. Fusarium infection after solidorgan transplantation. Clin Infect Dis 2001;32(8):1237-1240.

  17. Kleinschmidt-Demasters BK. Disseminated Fusarium infection with brain abscesses in a lung transplant recipient. Clin Neuropathol 2009;28(6):417-421.

  18. Wheeler MS, McGinnis MR, Schell WA, et al. Fusarium infection in burned patients. Am J Clin Pathol 1981;75(3):304-311.

  19. Paugam A, Baixench MT, Frank N, et al. Localized oral Fusarium infection in an AIDS patient with malignant lymphoma. J Infect 1999;39(2):153-154.

  20. Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect 2004;10 Suppl 1:67-75.

  21. Jahagirdar BN, Morrison VA. Emerging fungal pathogens in patients with hematologic malignancies and marrow/stem-cell transplant recipients. Semin Respir Infect 2002;17:113.

  22. Jossi M, Ambrosioni J, Macedo-Vinas M, et al. Invasive fusariosis with prolonged fungemia in a patient with acute lymphoblastic leukemia: case report and review of the literature. Int J Infect Dis 2010;14(4):354-356.

  23. Bourgeois GP, Cafardi JA, Sellheyer K et al. http://www.ncbi.nlm. nih.gov/pubmed?term=%22Andea AA%22%5BAuthor%5D. Disseminated Fusarium infection originating from paronychia in a neutropenic patient: a case report and review of the literature. Cutis 2010;85(4):191-194.

  24. King BA, Seropian S, Fox LP. Disseminated fusarium infection with muscle involvement. J Am Acad Dermatol 2011;65(1):235-237.

  25. Dai W, Dharamsi JW, Soliman S, et al. Cutaneous fusariosis developing in a post-irradiation site. Dermatol Online J 2011;17(5):5.

  26. Edupuganti S, Rouphael N, Mehta A, et al. Fusarium falciforme vertebral abscess and osteomyelitis: case report and molecular classification. J Clin Microbiol 2011;49(6):2350-2353.

  27. Rieger KE, Ridky TW, Sundram UN. Skin nodules in a patient with acute myeloid leukemia and neurological deterioration, quiz case. Disseminated fusariosis. Arch Dermatol 2010;146(9):1037-1042.

  28. Álvez F, Figueras C, Roselló E. Infecciones fúngicas invasivas emergentes. An Pediatr (Barc) 2010;73(1):52.e1-52.e6.

  29. Hsiue HC, Ruan SY, Kuo YL, et al. Invasive infections caused by non-Aspergillus moulds identified by sequencing analysis at a tertiary care hospital in Taiwan, 2000-2008. Clin Microbiol Infect 2010;16(8):1204-1206.

  30. Carneiro HA, Coleman JJ, Restrepo A, et al. Fusarium infection in lung transplant patients: report of 6 cases and review of the literature. Medicine (Baltimore) 2011;90(1):69-80.

  31. Lortholary O, Obenga G, Biswas P, et al. International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob Agents Chemother 2010;54(10):4446-4450.

  32. Perfect JR. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis 2005;40 Suppl 6:S401-8.

  33. Raad II, Hachem RY, Herbrecht R, et al. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis 2006;42(10):1398-1403.

  34. Bose P, Parekh HD, Holter JL, et al. Disseminated fusariosis occurring in two patients despite posaconazole prophylaxis.J Clin Microbiol 2011;49(4):1674-1675.




2020     |     www.medigraphic.com